Understanding and improving the prognosis of chronic kidney disease.
Chronic Kidney Disease Prognosis Consortium (CKD-PC)
This study is looking at chronic kidney disease (CKD) to better understand how it progresses and affects other health issues, so that doctors can create better ways to screen and manage the condition for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10898781 on NIH RePORTER |
What this research studies
This research focuses on chronic kidney disease (CKD), a significant global health issue affecting over 10% of the population. The Chronic Kidney Disease Prognosis Consortium (CKD-PC) brings together a large network of researchers and data from millions of individuals worldwide to enhance our understanding of CKD's progression and its impact on other health conditions. By analyzing data and developing risk assessment tools, the project aims to provide valuable insights that can inform clinical guidelines and improve patient care. Patients may benefit from improved screening and management strategies based on the findings.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults over 21 years old who are at risk for or currently diagnosed with chronic kidney disease.
Not a fit: Patients with acute kidney injury or those under 21 years old may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better risk assessment and management strategies for patients with chronic kidney disease.
How similar studies have performed: Previous research efforts in CKD prognosis have shown promise, indicating that large-scale collaborations can lead to significant advancements in understanding and managing the disease.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Coresh, Josef — New York University School of Medicine
- Study coordinator: Coresh, Josef
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.